| scholarly article | Q13442814 |
| P50 | author | Irene Oi-lin Ng | Q67487913 |
| P2093 | author name string | Alla Arzumanyan | |
| Mark A Feitelson | |||
| Zhaorui Lian | |||
| Marcia M Clayton | |||
| Tiffany Friedman | |||
| P2860 | cites work | Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells | Q24656933 |
| Proteasome complex as a potential cellular target of hepatitis B virus X protein | Q24681896 | ||
| The translation initiation factor, hu-Sui1 may be a target of hepatitis B X antigen in hepatocarcinogenesis | Q28141874 | ||
| Hepatitis B X-gene expression in hepatocellular carcinoma | Q67507097 | ||
| Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines | Q79716913 | ||
| Expression of epithelial cellular adhesion molecule (Ep-CAM) in chronic (necro-)inflammatory liver diseases and hepatocellular carcinoma | Q81644719 | ||
| Hepatocellular carcinoma | Q94473118 | ||
| The emerging role of EpCAM in cancer and stem cell signaling | Q28251164 | ||
| Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma | Q28257545 | ||
| A tumorigenic subpopulation with stem cell properties in melanomas | Q28277490 | ||
| Repression of Nanog gene transcription by Tcf3 limits embryonic stem cell self-renewal | Q28586947 | ||
| The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway | Q29615176 | ||
| Cadherin cell adhesion receptors as a morphogenetic regulator | Q29620503 | ||
| EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features | Q30493364 | ||
| Stem cells in hepatocarcinogenesis: evidence from genomic data | Q33533408 | ||
| The oncogenic activation of beta-catenin | Q33540073 | ||
| Trans-activation function of a 3' truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues | Q33707652 | ||
| Epithelial cell adhesion molecule regulation is associated with the maintenance of the undifferentiated phenotype of human embryonic stem cells | Q33726440 | ||
| Hepatitis B virus in hepatocarcinogenesis | Q33738444 | ||
| Truncated form of beta-catenin and reduced expression of wild-type catenins feature HepG2 human liver cancer cells. | Q33833436 | ||
| Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues | Q34417194 | ||
| Wnt signaling in liver cancer | Q35659072 | ||
| Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma | Q35764338 | ||
| Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling | Q36497297 | ||
| How is pluripotency determined and maintained? | Q36704169 | ||
| Characterization of adult prostatic progenitor/stem cells exhibiting self-renewal and multilineage differentiation | Q36713740 | ||
| Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses | Q36743649 | ||
| The role of epithelial-mesenchymal transition in cancer pathology | Q36845018 | ||
| microRNAs, RNA binding proteins and cancer | Q37757045 | ||
| Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis. | Q37894884 | ||
| Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling. | Q39640582 | ||
| Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A. | Q39907053 | ||
| Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin | Q40312516 | ||
| Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma | Q40361266 | ||
| The hepatitis B virus HBx protein induces adherens junction disruption in a src-dependent manner. | Q40796694 | ||
| Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer | Q41130614 | ||
| E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma | Q41149621 | ||
| Hepatitis B virus transcriptional activators: mechanisms and possible role in oncogenesis | Q41167238 | ||
| Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells. | Q44706836 | ||
| Hepatitis B virus-X protein recruits histone deacetylase 1 to repress insulin-like growth factor binding protein 3 transcription | Q45389152 | ||
| Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma | Q45423109 | ||
| Presence of antibodies to the polymerase gene product(s) of hepatitis B and woodchuck hepatitis virus in natural and experimental infections | Q45832305 | ||
| Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. | Q46615053 | ||
| Human embryonic genes re-expressed in cancer cells | Q48871469 | ||
| The phenotypes of pluripotent human hepatic progenitors. | Q52020121 | ||
| Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration. | Q53425046 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis B | Q6853 |
| liver cancer | Q623031 | ||
| neoplastic stem cells | Q1638475 | ||
| P304 | page(s) | 3701-3708 | |
| P577 | publication date | 2011-04-04 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? | |
| P478 | volume | 71 |
| Q58769412 | Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model |
| Q34993913 | Adult hepatic cavernous hemangioma with highly elevated α-fetoprotein: A case report and review of the literature |
| Q90308623 | BNIP3L-Dependent Mitophagy Promotes HBx-Induced Cancer Stemness of Hepatocellular Carcinoma Cells via Glycolysis Metabolism Reprogramming |
| Q38045627 | Biology and clinical implications of CD133(+) liver cancer stem cells. |
| Q40744258 | C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties. |
| Q33618740 | C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway. |
| Q36793453 | Cancer stem cells in the development of liver cancer |
| Q38174864 | Cellular reprogramming and hepatocellular carcinoma development |
| Q35661679 | Clinicopathologic characteristics of SALL4-immunopositive hepatocellular carcinoma |
| Q53272128 | Coexpression of stemness factors Oct4 and Nanog predict liver resection. |
| Q36511460 | Cytoplasmic EpCAM over-expression is associated with favorable clinical outcomes in pancreatic cancer patients with Hepatitis B virus negative infection |
| Q38894289 | DNA methylation consistency implicates the primary tumor cell origin of recurrent hepatocellular carcinoma. |
| Q39240497 | Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma |
| Q98771219 | Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets |
| Q40629212 | Evidence of Hepatitis B Virus Infection in Cancer and Noncancer Stem Cells Associated with Human Hepatocellular Carcinoma |
| Q37190302 | Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells. |
| Q42181540 | Expression of EpCAM increases in the hepatitis B related and the treatment-resistant hepatocellular carcinoma. |
| Q90321347 | HBV-TERT Promoter Integration Harnesses Host ELF4 Resulting in TERT Gene Transcription in Hepatocellular Carcinoma |
| Q36463282 | Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein |
| Q91598083 | Hepatitis B Virus Infection of Normal Hepatic Stem/Progenitor Cells |
| Q45325992 | Hepatitis B Virus-Associated Hepatocellular Carcinoma |
| Q52369573 | Hepatitis B Virus-Associated Hepatocellular Carcinoma and Hepatic Cancer Stem Cells. |
| Q45363162 | Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice |
| Q34915498 | Hepatitis B virus X (HBx) play an anti-apoptosis role in hepatic progenitor cells by activating Wnt/β-catenin pathway |
| Q37596738 | Hepatitis B virus X protein in liver tumor microenvironment |
| Q37744990 | Hepatitis B virus X protein promotes the stem-like properties of OV6+ cancer cells in hepatocellular carcinoma |
| Q39210813 | Hepatitis B virus X protein upregulates Lin28A/Lin28B through Sp-1/c-Myc to enhance the proliferation of hepatoma cells. |
| Q41924435 | Hepatitis B virus X protein-induced upregulation of CAT-1 stimulates proliferation and inhibits apoptosis in hepatocellular carcinoma cells |
| Q42241285 | Hepatitis C virus core protein regulates NANOG expression via the stat3 pathway |
| Q40766851 | Hepatocellular carcinoma: from hepatocyte to liver cancer stem cell |
| Q37711147 | Human viral oncogenesis: a cancer hallmarks analysis |
| Q36316724 | Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma |
| Q34256676 | MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma |
| Q28570720 | Nanog and β-catenin: a new convergence point in EpSC proliferation and differentiation |
| Q26830643 | Oncogenes and RNA splicing of human tumor viruses |
| Q28284012 | Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma |
| Q48196778 | Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization. |
| Q36257609 | Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis |
| Q46436038 | SALL4 immunoreactivity predicts prognosis in Western hepatocellular carcinoma patients but is a rare event: a study of 236 cases |
| Q26863339 | Shared mechanisms in stemness and carcinogenesis: lessons from oncogenic viruses |
| Q26773251 | Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma |
| Q38412315 | Significant biomarkers for the management of hepatocellular carcinoma |
| Q53382084 | Spalt-like transcription factor 4 immunopositivity is associated with epithelial cell adhesion molecule expression in combined hepatocellular carcinoma and cholangiocarcinoma. |
| Q83600789 | TGF-β1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p |
| Q38056849 | Tackling hepatitis B virus-associated hepatocellular carcinoma--the future is now. |
| Q26767061 | The Role of HPV in Head and Neck Cancer Stem Cell Formation and Tumorigenesis |
| Q39109959 | The evolving concept of liver cancer stem cells |
| Q35081469 | The roles of hepatitis B virus-encoded X protein in virus replication and the pathogenesis of chronic liver disease |
| Q28072845 | Transarterial Therapies for Hepatocellular Carcinoma |
| Q27692697 | Turning hepatic cancer stem cells inside out--a deeper understanding through multiple perspectives. |
| Q37260746 | USP16 Downregulation by Carboxyl-terminal Truncated HBx Promotes the Growth of Hepatocellular Carcinoma Cells |
| Q35796886 | Understanding cancer stem cell heterogeneity and plasticity. |
| Q42970471 | pIgR: frenemy of inflammation, EMT, and HCC progression |
| Q86011497 | β-catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study |
Search more.